Mass-tort marketing burns six-figure budgets on top-of-funnel intent traffic - TV spots, digital ads, radio buys - and then sells the leads downstream at high CPL. The question isn't whether the media is effective. It's whether the lead that reaches your inbox has been filtered for exposure window, certified jurisdiction, and MDL match before you pay for it.
LeadingResponse and Last10Legal both supply mass-tort leads to law firms. The difference is in the supply chain: one aggregates broadly from media buys, the other routes based on cohort-specific criteria. This comparison covers both honestly - including where LeadingResponse has a genuine scale advantage.
What LeadingResponse Is - and Where It Works
LeadingResponse is one of the larger mass-tort lead aggregators in the U.S. The business model is media-driven acquisition: buy TV airtime, digital ad inventory, and radio placements targeting potential claimants for active mass torts (Roundup, Camp Lejeune, PFAS, AFFF, talc, hair relaxer, Paraquat, 3M earplugs, and others). Consumers who respond to the media become leads that LeadingResponse packages and sells to law firms.
This media-first model has real advantages at scale:
Volume across multiple active torts. If your firm is running a multi-tort docket - Roundup plus Camp Lejeune plus PFAS simultaneously - a large aggregator with media spend across all of them can supply leads in volume you couldn't generate internally.
Established media infrastructure. Building effective mass-tort media campaigns (TV spot creative, media buying relationships, compliance-cleared ad copy) takes time and expertise. LeadingResponse has an existing infrastructure that most law firms would spend years building independently.
Speed to market on new torts. When a new MDL opens, an established aggregator can spin up lead flow quickly because the media-buying infrastructure already exists. A law firm starting its own acquisition campaign for a new tort faces a 3-6 month ramp.
Where the model shows friction:
Media-generated leads are top-of-funnel by nature. Someone who clicked a Facebook ad about Roundup settlements may or may not have a qualifying exposure. Aggregators running high-volume media buy at the top of the funnel - the filtering happens downstream, often after you've paid for the lead.
The questions that matter for mass tort lead quality: Was the claimant's exposure window verified before you paid? Is the jurisdiction certified for that MDL? Was the lead run through current MDL status (some torts have closed settlement periods, paused MDLs, or changed eligibility criteria)? The answer to all three determines whether a lead is a case or an invoice.
What Last10Legal Is - and When It Fits Better
Last10Legal's mass-tort supply chain works differently. Instead of media-buy aggregation, it uses a cohort routing engine: leads enter through a specific intake path, and the system matches them against tort-specific criteria before the lead is sent to a firm.
For each active tort in the cohort engine - including Roundup, Camp Lejeune, PFAS, AFFF, hair relaxer (uterine cancer), talc, Paraquat, 3M Combat Arms earplugs, Zantac, NEC baby formula, social media harm (Meta/TikTok MDL), and others - the routing applies:
- ·Exposure window verification: Does the claimant's timeline of use match the tort's qualifying exposure period?
- ·Jurisdiction matching: Is the claimant in a state where certified MDL counsel can accept the claim?
- ·MDL status check: Is the tort's MDL active, paused, or in a settlement period that affects new intake?
After passing these filters, the lead is routed to one firm with a 5-minute exclusivity window. Your firm pays when you unlock the lead - and what you're paying for is a filtered intake, not a raw media response.
When Last10Legal fits better:
You need cases, not leads. The distinction matters for mass tort economics. A raw media response costs less per unit but has a higher disqualification rate. A cohort-filtered intake costs more per unit but arrives with pre-screening that your paralegal team would otherwise do during intake.
Exposure-window accuracy matters for your docket. For torts with narrow or unusual exposure windows - PFAS from specific water system contamination, AFFF firefighting foam with verified occupational exposure, NEC baby formula for premature infants born in certain date ranges - broad media buys frequently pull in responses from people outside the qualifying window. Pre-filtering on exposure before routing saves your intake team hours per week.
Multi-state compliance. Last10Legal's routing screens for state-specific bar advertising rules before leads reach you. Operating in FL, TX, NY, LA, or NV with unscreened mass-tort leads from a media aggregator creates compliance exposure.
Cost-per-signed-case visibility. The pay-per-unlock model and single-firm routing make downstream attribution cleaner. You know which leads converted to signed cases because there's no competing firm that called the same claimant five minutes before you did.
Head-to-Head: Mass Tort Lead Supply Chain Comparison
The trade-off in plain terms: LeadingResponse gives you volume at top-of-funnel cost; Last10Legal gives you pre-filtered intakes at a higher per-unit cost with a lower wasted-intake rate.
Mass Tort Lead Economics - What the CPL Doesn't Tell You
CPL on media-generated mass-tort leads looks manageable on a spreadsheet. The downstream economics tell a more complex story.
A firm paying $400 CPL for Camp Lejeune leads from a media aggregator with a 20% qualification rate (after intake screening for exposure window and service period) is effectively paying $2,000 per qualified case before your paralegal's screening time and intake team cost.
A firm paying $600 per filtered intake from a cohort-routing platform with an 80% qualification rate is paying $750 per qualified case.
Those numbers are illustrative - the actual figures vary significantly by tort, MDL status, and market timing. But the pattern holds: qualification rate is the variable that determines real economics, not CPL.
Three things that compress qualification rate on media-generated mass-tort leads:
- Exposure window drift. TV ads run for months; the qualifying exposure window for the tort may be measured in years of specific product use ending at a specific date. Claimants who respond to a media buy often self-report exposure without understanding the qualifying window criteria.
- Jurisdiction overmatch. A national TV buy generates leads from states where no certified MDL counsel can take the claim or where the tort hasn't been active. You pay for the lead; you can't take the case.
- MDL timing gaps. Mass torts change status - settlement periods, pauses, new MDL consolidations. A media buy that was generating qualified leads three months ago may now be generating leads for a paused MDL. A platform with live MDL status integrated into routing adjusts in real time; a media aggregator running booked TV inventory doesn't.
Running the math on your current mass-tort lead source: divide your total spend (including intake team time) by signed cases, not leads. That number is your actual cost-per-case. Compare it honestly to a higher-CPL, higher-qualification-rate alternative before assuming the cheaper lead is the better deal.
Running Both - and When That Makes Sense
Some mass-tort firms use both: LeadingResponse (or similar aggregators) for volume on high-priority torts with active media markets, and Last10Legal for torts where exposure-window specificity matters more than volume.
This approach works when:
- ·Your intake capacity can handle high-volume screening from media buys AND the smaller, pre-filtered flow from cohort routing
- ·You want media-generated volume for torts where eligibility criteria are relatively simple, and cohort routing for torts with narrow or technically complex qualifying windows
If you're shifting from a media-aggregation model to a cohort-routing model:
- ·Track cost-per-signed-case separately for each source for 90 days before drawing conclusions
- ·Don't shut off volume until replacement intake is flowing - mass-tort dockets require consistent throughput
- ·Audit your current lead disqualification rate before switching. If you're disqualifying 60%+ of leads at intake, the economics of a filtered-but-higher-CPL model deserve serious evaluation
The right mix depends on your firm's intake capacity, your current docket's tort mix, and whether your competitive advantage is volume-throughput or case-selection precision.
Three Questions to Ask Any Mass Tort Lead Source
1. At what point in the pipeline is exposure window verified?
Before you pay for the lead? During your intake call? After you've already assigned a paralegal? The answer determines where the disqualification cost falls - on the platform or on your firm. Ask explicitly, and ask for disqualification rate data from firms running your specific tort.
2. How does your lead pricing change when MDL status changes?
Some torts go through paused periods, settlement class periods, or new MDL consolidations that affect lead quality dramatically. A platform running live media buys doesn't automatically stop when an MDL pauses. A cohort-routing system with live MDL status integration can. Ask what happens to your leads and your invoices when the MDL status changes.
3. Which states are certified for this tort, and does your routing exclude non-certified jurisdictions?
Mass torts require certified MDL counsel in certified jurisdictions. If a lead comes from a state where no certified MDL partner can accept the claim, you've paid for a lead you can't use. Ask for a certified jurisdiction list for your specific tort and verify that the platform filters on it.